Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat

Salvatore Cuzzocrea, Prabal K. Chatterjee, Emanuela Mazzon, Ivana Serraino, Laura Dugo, Tommaso Centorrino, Alberto Barbera, Antonio Ciccolo, Francesco Fulia, Michelle C. McDonald, Achille P. Caputi, Christoph Thiemermann

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: Zymosan enhances the formation of reactive oxygen species, which contributes to the pathophysiology of multiple organ failure. We investigated the effects of calpain inhibitor I (5, 10, or 20 mg/kg) on the multiple organ failure caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats. Setting: University research laboratory. Subjects: Male Sprague-Dawley rats. Interventions: Multiple organ failure in rats was assessed 18 hrs after administration of zymosan and/or calpain inhibitor I and was monitored for 12 days (for loss of body weight and mortality rate). Measurement and Main Results: Treatment of rats with calpain inhibitor I (5, 10, or 20 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan in a dose-dependent fashion. Calpain inhibitor I also attenuated the lung, liver, and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in the lung, liver, and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine-disphosphate-ribose) revealed positive staining in lung, liver, and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine-disphosphate-ribose) was reduced markedly in tissue sections obtained from zymosan-treated rats administered calpain inhibitor I (20 mg/kg intraperitoneally). Furthermore, treatment of rats with calpain inhibitor I significantly reduced the expression of inducible nitric oxide synthase and cyclooxygenase-2 in lung, liver, and intestine. Conclusion: This study provides the first evidence that calpain inhibitor I attenuates the degree of zymosan-induced multiple organ failure in the rat.

Original languageEnglish
Pages (from-to)2284-2294
Number of pages11
JournalCritical Care Medicine
Volume30
Issue number10
Publication statusPublished - Oct 1 2002

Fingerprint

Zymosan
Multiple Organ Failure
Intestines
Lung
Ribose
Liver
Adenosine
Staining and Labeling
calpain inhibitors
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Malondialdehyde
Peroxidase
Cell Movement
Sprague Dawley Rats
Reactive Oxygen Species
Suspensions
Histology
Body Weight
Mortality

Keywords

  • Calpain inhibitor I
  • Inducible nitric oxide synthase
  • Inflammation
  • Nitric oxide
  • Nuclear factor-κB
  • Zymosan-induced multiple organ failure

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Cuzzocrea, S., Chatterjee, P. K., Mazzon, E., Serraino, I., Dugo, L., Centorrino, T., ... Thiemermann, C. (2002). Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat. Critical Care Medicine, 30(10), 2284-2294.

Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat. / Cuzzocrea, Salvatore; Chatterjee, Prabal K.; Mazzon, Emanuela; Serraino, Ivana; Dugo, Laura; Centorrino, Tommaso; Barbera, Alberto; Ciccolo, Antonio; Fulia, Francesco; McDonald, Michelle C.; Caputi, Achille P.; Thiemermann, Christoph.

In: Critical Care Medicine, Vol. 30, No. 10, 01.10.2002, p. 2284-2294.

Research output: Contribution to journalArticle

Cuzzocrea, S, Chatterjee, PK, Mazzon, E, Serraino, I, Dugo, L, Centorrino, T, Barbera, A, Ciccolo, A, Fulia, F, McDonald, MC, Caputi, AP & Thiemermann, C 2002, 'Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat', Critical Care Medicine, vol. 30, no. 10, pp. 2284-2294.
Cuzzocrea S, Chatterjee PK, Mazzon E, Serraino I, Dugo L, Centorrino T et al. Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat. Critical Care Medicine. 2002 Oct 1;30(10):2284-2294.
Cuzzocrea, Salvatore ; Chatterjee, Prabal K. ; Mazzon, Emanuela ; Serraino, Ivana ; Dugo, Laura ; Centorrino, Tommaso ; Barbera, Alberto ; Ciccolo, Antonio ; Fulia, Francesco ; McDonald, Michelle C. ; Caputi, Achille P. ; Thiemermann, Christoph. / Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat. In: Critical Care Medicine. 2002 ; Vol. 30, No. 10. pp. 2284-2294.
@article{8865303daa0945daa14e3362d9256441,
title = "Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat",
abstract = "Objective: Zymosan enhances the formation of reactive oxygen species, which contributes to the pathophysiology of multiple organ failure. We investigated the effects of calpain inhibitor I (5, 10, or 20 mg/kg) on the multiple organ failure caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats. Setting: University research laboratory. Subjects: Male Sprague-Dawley rats. Interventions: Multiple organ failure in rats was assessed 18 hrs after administration of zymosan and/or calpain inhibitor I and was monitored for 12 days (for loss of body weight and mortality rate). Measurement and Main Results: Treatment of rats with calpain inhibitor I (5, 10, or 20 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan in a dose-dependent fashion. Calpain inhibitor I also attenuated the lung, liver, and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in the lung, liver, and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine-disphosphate-ribose) revealed positive staining in lung, liver, and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine-disphosphate-ribose) was reduced markedly in tissue sections obtained from zymosan-treated rats administered calpain inhibitor I (20 mg/kg intraperitoneally). Furthermore, treatment of rats with calpain inhibitor I significantly reduced the expression of inducible nitric oxide synthase and cyclooxygenase-2 in lung, liver, and intestine. Conclusion: This study provides the first evidence that calpain inhibitor I attenuates the degree of zymosan-induced multiple organ failure in the rat.",
keywords = "Calpain inhibitor I, Inducible nitric oxide synthase, Inflammation, Nitric oxide, Nuclear factor-κB, Zymosan-induced multiple organ failure",
author = "Salvatore Cuzzocrea and Chatterjee, {Prabal K.} and Emanuela Mazzon and Ivana Serraino and Laura Dugo and Tommaso Centorrino and Alberto Barbera and Antonio Ciccolo and Francesco Fulia and McDonald, {Michelle C.} and Caputi, {Achille P.} and Christoph Thiemermann",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "30",
pages = "2284--2294",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat

AU - Cuzzocrea, Salvatore

AU - Chatterjee, Prabal K.

AU - Mazzon, Emanuela

AU - Serraino, Ivana

AU - Dugo, Laura

AU - Centorrino, Tommaso

AU - Barbera, Alberto

AU - Ciccolo, Antonio

AU - Fulia, Francesco

AU - McDonald, Michelle C.

AU - Caputi, Achille P.

AU - Thiemermann, Christoph

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Objective: Zymosan enhances the formation of reactive oxygen species, which contributes to the pathophysiology of multiple organ failure. We investigated the effects of calpain inhibitor I (5, 10, or 20 mg/kg) on the multiple organ failure caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats. Setting: University research laboratory. Subjects: Male Sprague-Dawley rats. Interventions: Multiple organ failure in rats was assessed 18 hrs after administration of zymosan and/or calpain inhibitor I and was monitored for 12 days (for loss of body weight and mortality rate). Measurement and Main Results: Treatment of rats with calpain inhibitor I (5, 10, or 20 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan in a dose-dependent fashion. Calpain inhibitor I also attenuated the lung, liver, and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in the lung, liver, and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine-disphosphate-ribose) revealed positive staining in lung, liver, and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine-disphosphate-ribose) was reduced markedly in tissue sections obtained from zymosan-treated rats administered calpain inhibitor I (20 mg/kg intraperitoneally). Furthermore, treatment of rats with calpain inhibitor I significantly reduced the expression of inducible nitric oxide synthase and cyclooxygenase-2 in lung, liver, and intestine. Conclusion: This study provides the first evidence that calpain inhibitor I attenuates the degree of zymosan-induced multiple organ failure in the rat.

AB - Objective: Zymosan enhances the formation of reactive oxygen species, which contributes to the pathophysiology of multiple organ failure. We investigated the effects of calpain inhibitor I (5, 10, or 20 mg/kg) on the multiple organ failure caused by zymosan (500 mg/kg, administered intraperitoneally as a suspension in saline) in rats. Setting: University research laboratory. Subjects: Male Sprague-Dawley rats. Interventions: Multiple organ failure in rats was assessed 18 hrs after administration of zymosan and/or calpain inhibitor I and was monitored for 12 days (for loss of body weight and mortality rate). Measurement and Main Results: Treatment of rats with calpain inhibitor I (5, 10, or 20 mg/kg intraperitoneally, 1 and 6 hrs after zymosan) attenuated the peritoneal exudation and the migration of polymorphonuclear cells caused by zymosan in a dose-dependent fashion. Calpain inhibitor I also attenuated the lung, liver, and intestinal injury (histology) as well as the increase in myeloperoxidase activity and malondialdehyde concentrations caused by zymosan in the lung, liver, and intestine. Immunohistochemical analysis for nitrotyrosine and for poly(adenosine-disphosphate-ribose) revealed positive staining in lung, liver, and intestine from zymosan-treated rats. The degree of staining for nitrotyrosine and poly(adenosine-disphosphate-ribose) was reduced markedly in tissue sections obtained from zymosan-treated rats administered calpain inhibitor I (20 mg/kg intraperitoneally). Furthermore, treatment of rats with calpain inhibitor I significantly reduced the expression of inducible nitric oxide synthase and cyclooxygenase-2 in lung, liver, and intestine. Conclusion: This study provides the first evidence that calpain inhibitor I attenuates the degree of zymosan-induced multiple organ failure in the rat.

KW - Calpain inhibitor I

KW - Inducible nitric oxide synthase

KW - Inflammation

KW - Nitric oxide

KW - Nuclear factor-κB

KW - Zymosan-induced multiple organ failure

UR - http://www.scopus.com/inward/record.url?scp=0036799849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036799849&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 2284

EP - 2294

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 10

ER -